Health
Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures – News-Medical.Net
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin…
Finding a potential therapeutic target to battle the coronavirus disease 2019 (COVID-19) pandemic is crucial. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus has now spread to 191 countries worldwide and has infected over 59.17 million people.
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin can inhibit viral replication by preventing SARS-CoV-2…
-
General17 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
General13 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
General12 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
Noosa News13 hours agoAccredited Specialists making a difference – Proctor